Nippon India Pharma Fund - Direct Growth
Summary Info Open Free MF account now
Login to invest now
| Fund Name | : | Nippon India Mutual Fund |
| Scheme Name | : | Nippon India Pharma Fund - Direct Growth |
| AMC | : | Nippon India Mutual Fund |
| Type | : | Open |
| Category | : | Equity - Pharma |
| Launch Date | : | 01-Jan-13 |
| Fund Manager | : | Sailesh Raj Bhan |
| Net Assets (Rs. cr) | : | 4383.33 |
Nippon India Pharma Fund - Direct Growth - NAV Details
| NAV Date | : | 15-Jan-21 |
| NAV [Rs.] | : | 275.75 |
| Buy/Resale Price [Rs.] | : | 0 |
| Sell/Repurchase Price [Rs.] | : | 0 |
| Entry Load % | : | |
| Exit Load % | : | Nil |
Nippon India Pharma Fund - Direct Growth - NAV Chart
Nippon India Pharma Fund - Direct Growth - Performance(%)
* returns above 1 yr. are annualized
| 1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
| Scheme Returns | [1.42] | 5.08 | 14.03 | 33.86 | 67.67 | 22.55 | 14.13 | 18.62 |
| Category Avg | [1.25] | 4.34 | 12.40 | 34.17 | 65.32 | 19.05 | 10.93 | 24.63 |
| Category Best | [0.63] | 5.66 | 14.18 | 40.99 | 76.12 | 22.55 | 14.13 | 42.92 |
| Category Worst | [1.98] | 2.74 | 9.82 | 27.57 | 53.16 | 15.15 | 7.97 | 8.73 |
Nippon India Pharma Fund - Direct Growth - Latest Dividends
| Dividends | Bonus | |
| Ratio | NA | NA |
| Date | NA | NA |
Nippon India Pharma Fund - Direct Growth - Investment Details
| Min. Investment(Rs.) | : | 5000 |
| Increm.Investment(Rs.) | : | 1 |
In & Out
| In | |
| Name of the Company | No of shares |
| No Data Found | |
| Out | |
| Name of the Company | No of shares |
| No Data Found | |
Fund Holdings
| Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals | 10.81 | 8,000,976.00 | 473.94 |
| Equity | Aurobindo Pharma | Pharmaceuticals | 10.51 | 5,000,000.00 | 460.65 |
| Equity | Cipla | Pharmaceuticals | 9.35 | 5,000,000.00 | 409.98 |
| Equity | Divi's Lab. | Pharmaceuticals | 9.20 | 1,050,000.00 | 403.40 |
| Equity | Lupin | Pharmaceuticals | 8.91 | 4,000,025.00 | 390.74 |
| Equity | Dr Reddy's Labs | Pharmaceuticals | 8.91 | 750,000.00 | 390.38 |
| Equity | Cadila Health. | Pharmaceuticals | 6.52 | 5,998,982.00 | 286 |
| Equity | Fortis Health. | Healthcare Services | 5.67 | 16,003,541.00 | 248.38 |
| Equity | Gland Pharma | Healthcare Services | 4.35 | 814,523.00 | 190.58 |
| Equity | Thyrocare Tech. | Healthcare Services | 4.25 | 2,041,561.00 | 186.39 |
| Equity | Narayana Hrudaya | Healthcare Services | 4.09 | 4,000,881.00 | 179.30 |
| Equity | Apollo Hospitals | Healthcare Services | 2.75 | 500,395.00 | 120.74 |
| Equity | Sanofi India | Pharmaceuticals | 2.75 | 144,670.00 | 120.47 |
| Equity | Abbott India | Pharmaceuticals | 2.55 | 70,971.00 | 111.91 |
| Equity | Indoco Remedies | Pharmaceuticals | 2.35 | 3,390,190.00 | 103.08 |
| Equity | Biocon | Pharmaceuticals | 2.13 | 2,003,178.00 | 93.23 |
| Equity | Shilpa Medicare | Pharmaceuticals | 0.72 | 700,000.00 | 31.52 |
| Equity | Torrent Pharma. | Pharmaceuticals | 0.64 | 100,000.00 | 28.03 |
| Equity | Syngene Intl. | Pharmaceuticals | 0.56 | 382,661.00 | 24.48 |
| Equity | Health.Global | Healthcare Services | 0.43 | 1,162,723.00 | 18.92 |
| Equity | Alkem Lab | Pharmaceuticals | 0.26 | 38,688.00 | 11.32 |
| Derivative Investments | |||||
| Derivatives | Derivatives | -/- | 0.33 | 0.00 | 14.35 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 2.44 | 0.00 | 107.03 |
| Cash & Cash Equivalent | C C I | -/- | 0 | 0.00 | 0.10 |
| Net CA & Others | Net CA & Others | -/- | [0.48] | 0.00 | [21.58] |
Fund Manager Speak
Sachin Trivedi, Equity Fund Manager & Head of Research, UTI Asset Management Company
Growth will come back and people will take time to adjust, which is why we will spend the next 1-1.5 years in a consolidation phase....
Key Information
| Fund House | : Nippon India Mutual Fund |
| Incorporation Date | : 24-Feb-1995 |
| Total Assets Managed (Cr.) | : 214,416.09 |
| Trustee/s | : Nippon Life India Trustee |
| Chairman | : N/A |
| CEO / MD | : Mr. Sundeep Sikka |
| CIO | : N/A |
| President | : N/A |
| Director/s | : Mr. Takayuki Murai |
| Compliance Officer/s | : Mr. Muneesh Sud |
| Investor Service Officer/s | : Mr. Bhalchandra Joshi |
| Fund Manager/s | : Sailesh Raj Bhan |
Other Information
| Auditors | : N/A |
| Registered Office | : 4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013. |
| Contact Nos | : 022-68087000 |
| Fax | : 022-68087097 |
| : customercare@nipponindiamf.com | |
| Website | : www.nipponindiamf.com |
